Scientists at the University of California, San Francisco are recreating early development, then leaving it up to cells to fold themselves into complex human…
Scientists at UCLA are among those investigating whether immune cells known as chimeric antigen receptor T cells (CAR-Ts) would work against HIV.
Scientists are looking to deploy CRISPR in genetic deafness—and they have their first evidence that their technique may hold promise.
Biotech discoveries over the past week include an unexpected weapon against dormant HIV and evidence that a shelved antibiotic may be worthwhile after all.
Scientists at Walter Reed have developed a heroin vaccine to block the euphoric effects of opioids without interfering with other anti-addiction therapies.
Alnylam, which put its hemophilia program on hold in September, has gotten the all-clear from the FDA to resume trials.
A Stanford team aimed at host cells to fight flaviviruses, while Harvard scientists examined the longevity of Zika vaccines.
Scientists believe they've discovered a novel gene that can be inhibited with antisense technology to treat cancer.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
Two new research insights might help make checkpoint inhibition an effective option for many more lung cancer patients.